Filed: 2/12/2026ACC: 0001420506-26-000321
📋 What this filing means
SILVERARC CAPITAL MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 68 equity positions with a total reported market value of $720.05M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
68
Positions
$720.05M
Total AUM (reported)
52.59M
Total Shares
Allocation by class
COM$515.28M71.6%
SPONSORED ADS$69.37M9.6%
COM NEW$66.02M9.2%
CALL$28.90M4.0%
COM PAR $.01$12.40M1.7%
SPONSORED ADR$10.50M1.5%
ORD$5.32M0.7%
Portfolio Concentration
Top 3$141.89M19.7%
4–10$215.96M30.0%
11–25$201.43M28.0%
Rest$160.77M22.3%
Top 3 weight
19.7%
Top 10 weight
49.7%
Voting Authority Distribution
Total shares with voting rights: 52.59M
Sole
Full voting authority
52.59M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole68
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings68
Rows:
ABIVAX SA
SOLEShares422.19K
TypeSH
Market value$56.93M
7.91%
Sole
422.19K
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares1.25M
TypeSH
Market value$44.23M
6.14%
Sole
1.25M
Shared
0.00
None
0.00
UROGEN PHARMA LTD
SOLEShares1.74M
TypeSH
Market value$40.72M
5.66%
Sole
1.74M
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares2.43M
TypeSH
Market value$39.20M
5.44%
Sole
2.43M
Shared
0.00
None
0.00
CELCUITY INC
SOLEShares375.13K
TypeSH
Market value$37.42M
5.20%
Sole
375.13K
Shared
0.00
None
0.00
NUVALENT INC
SOLEShares311.43K
TypeSH
Market value$31.33M
4.35%
Sole
311.43K
Shared
0.00
None
0.00
DIANTHUS THERAPEUTICS INC
SOLEShares750.14K
TypeSH
Market value$30.91M
4.29%
Sole
750.14K
Shared
0.00
None
0.00
KODIAK SCIENCES INC
SOLEShares1.02M
TypeSH
Market value$28.61M
3.97%
Sole
1.02M
Shared
0.00
None
0.00
PRAXIS PRECISION MEDICINES I
SOLEShares82.47K
TypeSH
Market value$24.31M
3.38%
Sole
82.47K
Shared
0.00
None
0.00
IMMUNOME INC
SOLEShares1.13M
TypeSH
Market value$24.19M
3.36%
Sole
1.13M
Shared
0.00
None
0.00
FRACTYL HEALTH INC
SOLEShares9.84M
TypeSH
Market value$21.65M
3.01%
Sole
9.84M
Shared
0.00
None
0.00
UNIQURE NV
SOLEShares720.80K
TypeSH
Market value$17.25M
2.40%
Sole
720.80K
Shared
0.00
None
0.00
MONTE ROSA THERAPEUTICS INC
SOLEShares1.03M
TypeSH
Market value$16.14M
2.24%
Sole
1.03M
Shared
0.00
None
0.00
VERACYTE INC
SOLEShares357.56K
TypeSH
Market value$15.05M
2.09%
Sole
357.56K
Shared
0.00
None
0.00
CG ONCOLOGY INC
SOLEShares361.16K
TypeSH
Market value$15.00M
2.08%
Sole
361.16K
Shared
0.00
None
0.00
RHYTHM PHARMACEUTICALS INC
SOLEShares135.95K
TypeSH
Market value$14.55M
2.02%
Sole
135.95K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares642.90K
TypeSH
Market value$13.51M
1.88%
Sole
642.90K
Shared
0.00
None
0.00
BIOGEN INC
SOLEShares75.41K
TypeSH
Market value$13.27M
1.84%
Sole
75.41K
Shared
0.00
None
0.00
INSMED INC
SOLEShares71.26K
TypeSH
Market value$12.40M
1.72%
Sole
71.26K
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS PLC
SOLEShares458.20K
TypeSH
Market value$11.46M
1.59%
Sole
458.20K
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares348.57K
TypeSH
Market value$10.85M
1.51%
Sole
348.57K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares49.23K
TypeSH
Market value$10.50M
1.46%
Sole
49.23K
Shared
0.00
None
0.00
PFIZER INC
SOLEShares419.13K
TypeSH
Market value$10.44M
1.45%
Sole
419.13K
Shared
0.00
None
0.00
BENITEC BIOPHARMA INC
SOLEShares731.72K
TypeSH
Market value$9.86M
1.37%
Sole
731.72K
Shared
0.00
None
0.00
AVALO THERAPEUTICS INC
SOLEShares524.44K
TypeSH
Market value$9.52M
1.32%
Sole
524.44K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ABIVAX SASOLE | SPONSORED ADS | 422.19K | SH | $56.93M 7.91% | 422.19K | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 1.25M | SH | $44.23M 6.14% | 1.25M | 0.00 | 0.00 |
UROGEN PHARMA LTDSOLE | COM | 1.74M | SH | $40.72M 5.66% | 1.74M | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 2.43M | SH | $39.20M 5.44% | 2.43M | 0.00 | 0.00 |
CELCUITY INCSOLE | COM | 375.13K | SH | $37.42M 5.20% | 375.13K | 0.00 | 0.00 |
NUVALENT INCSOLE | COM | 311.43K | SH | $31.33M 4.35% | 311.43K | 0.00 | 0.00 |
DIANTHUS THERAPEUTICS INCSOLE | COM | 750.14K | SH | $30.91M 4.29% | 750.14K | 0.00 | 0.00 |
KODIAK SCIENCES INCSOLE | COM | 1.02M | SH | $28.61M 3.97% | 1.02M | 0.00 | 0.00 |
PRAXIS PRECISION MEDICINES ISOLE | COM NEW | 82.47K | SH | $24.31M 3.38% | 82.47K | 0.00 | 0.00 |
IMMUNOME INCSOLE | COM | 1.13M | SH | $24.19M 3.36% | 1.13M | 0.00 | 0.00 |
FRACTYL HEALTH INCSOLE | COM | 9.84M | SH | $21.65M 3.01% | 9.84M | 0.00 | 0.00 |
UNIQURE NVSOLE | CALL | 720.80K | SH | $17.25M 2.40% | 720.80K | 0.00 | 0.00 |
MONTE ROSA THERAPEUTICS INCSOLE | COM | 1.03M | SH | $16.14M 2.24% | 1.03M | 0.00 | 0.00 |
VERACYTE INCSOLE | COM | 357.56K | SH | $15.05M 2.09% | 357.56K | 0.00 | 0.00 |
CG ONCOLOGY INCSOLE | COM | 361.16K | SH | $15.00M 2.08% | 361.16K | 0.00 | 0.00 |
RHYTHM PHARMACEUTICALS INCSOLE | COM | 135.95K | SH | $14.55M 2.02% | 135.95K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 642.90K | SH | $13.51M 1.88% | 642.90K | 0.00 | 0.00 |
BIOGEN INCSOLE | COM | 75.41K | SH | $13.27M 1.84% | 75.41K | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 71.26K | SH | $12.40M 1.72% | 71.26K | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS PLCSOLE | SPONSORED ADS | 458.20K | SH | $11.46M 1.59% | 458.20K | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 348.57K | SH | $10.85M 1.51% | 348.57K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 49.23K | SH | $10.50M 1.46% | 49.23K | 0.00 | 0.00 |
PFIZER INCSOLE | COM | 419.13K | SH | $10.44M 1.45% | 419.13K | 0.00 | 0.00 |
BENITEC BIOPHARMA INCSOLE | COM NEW | 731.72K | SH | $9.86M 1.37% | 731.72K | 0.00 | 0.00 |
AVALO THERAPEUTICS INCSOLE | COM NEW | 524.44K | SH | $9.52M 1.32% | 524.44K | 0.00 | 0.00 |
Page 1 of 3